Showing results (1231-1240 of 2,125) with videos related to
Sort By:
Pageof 213
Journal of Ovarian Research|November 28, 2013
MiR-124 inhibits the migration and invasion of ovarian cancer cells by targeting SphK1Hanwen Zhang, Qiuyu Wang, Qian Zhao, et al.Journal of Ovarian Research|December 17, 2013
Relative expression of proprotein convertases in rat ovaries during pregnancySimon Cm Kwok, Damayanti Chakraborty, Michael J Soares, et al.Journal of Ovarian Research|September 26, 2013
The effect of calorie restriction on the presence of apoptotic ovarian cells in normal wild type mice and low-plasma-IGF-1 Laron dwarf miceSylwia Słuczanowska-Głąbowska, Maria Laszczyńska, Katarzyna Piotrowska, et al.Journal of Ovarian Research|October 2, 2013
Pioglitazone counteracts the tumor necrosis factor-α inhibition of follicle-stimulating hormone-induced follicular development and estradiol production in an in vitro mouse preantral follicle culture systemShuichiro Hara, Toshifumi Takahashi, Mitsuyoshi Amita, et al.Journal of Ovarian Research|August 28, 2016
Genomic alterations in neuroendocrine cancers of the ovaryGeorge Yaghmour, Philippe Prouet, Eric Wiedower, et al.Journal of Ovarian Research|August 26, 2016
Application of receiver operating characteristic curve in the assessment of the value of body mass index, waist circumference and percentage of body fat in the Diagnosis of Polycystic Ovary Syndrome in childbearing womenPan Dou, Huiyan Ju, Jing Shang, et al.Journal of Ovarian Research|August 26, 2016
Long-term storage does not impact the quality of cryopreserved human ovarian tissueRaffaella Fabbri, Maria Macciocca, Rossella Vicenti, et al.Journal of Ovarian Research|September 23, 2018
Assessment of Prostaglandin-Endoperoxide Synthase 2 and Versican gene expression profile from the cumulus cells: association with better in vitro fertilization outcomesAzucena Ocampo, Jeimy Pedraza, Ginna Ortiz, et al.Journal of Ovarian Research|September 28, 2018
Intrafollicular fibroblast growth factor 13 in polycystic ovary syndrome: relationship with androgen levels and oocyte developmental competenceYu Liu, Shengxian Li, Tao Tao, et al.Journal of Ovarian Research|April 28, 2019
Use of a multi-drug regimen gemcitabine, 5-fluorouracil, irinotecan, cisplatin, bevacizumab, docetaxel, and cyclophosphamide (GFIP/BDC) for heavily pretreated relapsed epithelial ovarian, fallopian tube and primary peritoneal cancerSamantha Cohen, Melissa Schwartz, Peter Dottino, et al.Pageof 213